Epidermal growth factor receptor overexpression, or constitutive activation, has been implicated in the progression of a variety of cancers including lung, head and neck, colon, brain, and breast cancer by promoting tumor angiogenesis and metastasis (10, 26–31). This evidence concerns the gene EGFR and breast cancer.